OAM
SURF

Oxford Asset Management’s Surface Oncology, Inc. Common Stock SURF Stock Holding History

Oxford Asset Management’s Portfolio SURF Stock Details SURF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-26,419
Closed -$75K – 2006
2019
Q2 		$75K Buy
26,419
+4,219
+19% +$16.8K ﹤0.01% 1625
2019
Q1 		$106K Sell
22,200
-25,819
-54% -$127K ﹤0.01% 1566
2018
Q4 		$204K Buy
+48,019
New +$371K 0.01% 1528

Other funds holding SURF

AVAI
Atlas Venture Associates IX Boston, Massachusetts $11.8M AUM 58.35% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oxford Asset Management's SURF Position: Q3 2019 in Review

Oxford Asset Management sold out of Surface Oncology, Inc. Common Stock (SURF) in Q3 2019, closing a stake of 26,419 shares — an estimated $75K sold.

Oxford Asset Management first reported a position in SURF in Q4 2018 and held it in 3 quarters. The position peaked at $204K in Q4 2018. 35 funds tracked by Wall St. Rank hold SURF as of Q3 2019.

  • Oxford Asset Management reported no remaining Surface Oncology, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Oxford Asset Management sold 26,419 Surface Oncology, Inc. Common Stock shares in Q3 2019, an estimated $75K.
  • Oxford Asset Management first reported a position in Surface Oncology, Inc. Common Stock in Q4 2018 and held it in 3 quarters.
  • Oxford Asset Management's Surface Oncology, Inc. Common Stock position peaked at $204K in Q4 2018.
  • 35 funds tracked by Wall St. Rank held Surface Oncology, Inc. Common Stock as of Q3 2019.

Based on Oxford Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.